Propionibacterium acnes phylogenetic type III is associated with progressive macular hypomelanosis

Rolf L. W. Petersen,Christian F. P. Scholz,Anders Jensen,Holger Brüggemann,Hans B. Lomholt
DOI: https://doi.org/10.1556/1886.2016.00040
2017-03-01
European Journal of Microbiology and Immunology
Abstract:Progressive macular hypomelanosis (PMH) is a skin disorder that is characterized by hypopigmented macules and usually seen in young adults. The skin microbiota, in particular the bacterium <i>Propionibacterium acnes</i>, is suggested to play a role. Here, we compared the <i>P. acnes</i> population of 24 PMH lesions from eight patients with corresponding nonlesional skin of the patients and matching control samples from eight healthy individuals using an unbiased, culture-independent next-generation sequencing approach. We also compared the <i>P. acnes</i> population before and after treatment with a combination of lymecycline and benzoylperoxide. We found an association of one subtype of <i>P. acnes</i>, type III, with PMH. This type was predominant in all PMH lesions (73.9% of reads in average) but only detected as a minor proportion in matching control samples of healthy individuals (14.2% of reads in average). Strikingly, successful PMH treatment is able to alter the composition of the <i>P. acnes</i> population by substantially diminishing the proportion of <i>P. acnes</i> type III. Our study suggests that <i>P. acnes</i> type III may play a role in the formation of PMH. Furthermore, it sheds light on substantial differences in the <i>P. acnes</i> phylotype distribution between the upper and lower back and abdomen in healthy individuals.
What problem does this paper attempt to address?